Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose...
Sep 2, 2025, 8:00 AM EDT - 4 weeks ago
Aug 26, 2025, 8:00 AM EDT - 5 weeks ago
Aug 16, 2025, 12:25 AM EDT - 7 weeks ago
BLSH BUUU KLAR MAGH MIAX NUTR PPCB
Aug 14, 2025, 4:05 PM EDT - 7 weeks ago
Aug 13, 2025, 7:30 AM EDT - 7 weeks ago
Jul 16, 2025, 11:14 AM EDT - 2 months ago
Jul 9, 2025, 5:40 PM EDT - 3 months ago
Jul 9, 2025, 3:59 PM EDT - 3 months ago